Clinical Trial Update: Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

A comparative pharmacokinetic, pharmacodynamic, safety and efficacy study of three anti-CD20 monoclonal antibodies in patients with moderate to severe rheumatoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-01-13